메뉴 건너뛰기




Volumn 28, Issue 6, 2013, Pages 1328-1336

Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene

Author keywords

ALENDRONATE; FINITE ELEMENT ANALYSIS; POSTMENOPAUSAL OSTEOPOROSIS; RALOXIFENE; TERIPARATIDE

Indexed keywords

ALENDRONIC ACID; ESTROGEN RECEPTOR; PARATHYROID HORMONE[1-34]; RALOXIFENE;

EID: 84878263922     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1853     Document Type: Article
Times cited : (73)

References (28)
  • 2
    • 67649382241 scopus 로고    scopus 로고
    • Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment
    • Apr;.
    • Prevrhal S, Krege JH, Chen P, Genant H, Black DM., Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment. Curr Med Res Opin. 2009 Apr; 25 (4): 921-8.
    • (2009) Curr Med Res Opin. , vol.25 , Issue.4 , pp. 921-928
    • Prevrhal, S.1    Krege, J.H.2    Chen, P.3    Genant, H.4    Black, D.M.5
  • 3
    • 80355132768 scopus 로고    scopus 로고
    • Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis
    • Jan;.
    • Krege JH, Wan X., Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis. Bone. 2012 Jan; 50 (1): 161-4.
    • (2012) Bone , vol.50 , Issue.1 , pp. 161-164
    • Krege, J.H.1    Wan, X.2
  • 8
    • 3242762388 scopus 로고    scopus 로고
    • Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate
    • May;.
    • Ettinger B, San Martin J, Crans G, Pavo I., Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res. 2004 May; 19 (5): 745-51.
    • (2004) J Bone Miner Res. , vol.19 , Issue.5 , pp. 745-751
    • Ettinger, B.1    San Martin, J.2    Crans, G.3    Pavo, I.4
  • 11
    • 23444435838 scopus 로고    scopus 로고
    • Daily and cyclic parathyroid hormone in women receiving alendronate
    • Aug;.
    • Cosman F, Nieves J, Zion M, Woelfert L, Luckey M, Lindsay R., Daily and cyclic parathyroid hormone in women receiving alendronate. N Engl J Med. 2005 Aug; 353 (6): 566-75.
    • (2005) N Engl J Med. , vol.353 , Issue.6 , pp. 566-575
    • Cosman, F.1    Nieves, J.2    Zion, M.3    Woelfert, L.4    Luckey, M.5    Lindsay, R.6
  • 12
    • 47249089119 scopus 로고    scopus 로고
    • Effect of prior and ongoing raloxifene therapy on response to PTH therapy
    • Apr;.
    • Cosman F, Nieves JW, Zion M, Barbuto N, Lindsay R., Effect of prior and ongoing raloxifene therapy on response to PTH therapy. Osteoporos Int. 2008 Apr; 19 (4): 529-35.
    • (2008) Osteoporos Int. , vol.19 , Issue.4 , pp. 529-535
    • Cosman, F.1    Nieves, J.W.2    Zion, M.3    Barbuto, N.4    Lindsay, R.5
  • 13
    • 44649116491 scopus 로고    scopus 로고
    • Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    • Jul;.
    • Wermers RA, Recknor CP, Cosman F, Xie L, Glass EV, Krege JH., Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate. Osteoporos Int. 2008 Jul; 19 (7): 1055-65.
    • (2008) Osteoporos Int. , vol.19 , Issue.7 , pp. 1055-1065
    • Wermers, R.A.1    Recknor, C.P.2    Cosman, F.3    Xie, L.4    Glass, E.V.5    Krege, J.H.6
  • 14
    • 70349897684 scopus 로고    scopus 로고
    • Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent
    • Oct;.
    • Cosman F, Wermers RA, Recknor C, Mauck KF, Xie L, Glass EV, Krege JH., Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent. J Clin Endocrinol Metab. 2009 Oct; 94 (10): 3772-80.
    • (2009) J Clin Endocrinol Metab. , vol.94 , Issue.10 , pp. 3772-3780
    • Cosman, F.1    Wermers, R.A.2    Recknor, C.3    Mauck, K.F.4    Xie, L.5    Glass, E.V.6    Krege, J.H.7
  • 15
    • 52949090528 scopus 로고    scopus 로고
    • Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans
    • Dec;.
    • Keaveny TM, Hoffmann PF, Singh M, Palermo LK, Bilezikian JP, Greenspan SL, Black DM., Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008 Dec; 23 (12): 1974-82.
    • (2008) J Bone Miner Res. , vol.23 , Issue.12 , pp. 1974-1982
    • Keaveny, T.M.1    Hoffmann, P.F.2    Singh, M.3    Palermo, L.K.4    Bilezikian, J.P.5    Greenspan, S.L.6    Black, D.M.7
  • 16
    • 80355125313 scopus 로고    scopus 로고
    • Femoral strength in osteoporotic women treated with teriparatide or alendronate
    • Jan;.
    • Keaveny TM, McClung WR, Wan X, Kopperdahl DL, Mitlak BH, Krohn K., Femoral strength in osteoporotic women treated with teriparatide or alendronate. Bone. 2012 Jan; 50 (1): 165-70.
    • (2012) Bone , vol.50 , Issue.1 , pp. 165-170
    • Keaveny, T.M.1    McClung, W.R.2    Wan, X.3    Kopperdahl, D.L.4    Mitlak, B.H.5    Krohn, K.6
  • 17
    • 77950657111 scopus 로고    scopus 로고
    • Biomechanical computed tomography - Non-invasive bone strength analysis using clinical CT scans
    • Mar.
    • Keaveny TM., Biomechanical computed tomography-non-invasive bone strength analysis using clinical CT scans. Ann NY Acad Sci. 2010 Mar; 1192: 57-65.
    • (2010) Ann NY Acad Sci. , vol.1192 , pp. 57-65
    • Keaveny, T.M.1
  • 18
    • 33845955242 scopus 로고    scopus 로고
    • Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis
    • Jan;.
    • Keaveny TM, Donley DW, Hoffman PF, Mitlak BH, Glass EV, San Martin JA., Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res. 2007 Jan; 22 (1): 149-57.
    • (2007) J Bone Miner Res. , vol.22 , Issue.1 , pp. 149-157
    • Keaveny, T.M.1    Donley, D.W.2    Hoffman, P.F.3    Mitlak, B.H.4    Glass, E.V.5    San Martin, J.A.6
  • 20
    • 84863388595 scopus 로고    scopus 로고
    • Osteoporotic Fractions in Men (MrOS) Research Group, Keaveny TM. Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans
    • Apr;.
    • Wang X, Sanyal A, Cawthon PM, Palermo L, Jekir M, Christensen J, Ensrud KE, Cummings SR, Orwoll E, Black DM., Osteoporotic Fractions in Men (MrOS) Research Group, Keaveny TM. Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. J Bone Miner Res. 2012 Apr; 27 (4): 808-16.
    • (2012) J Bone Miner Res. , vol.27 , Issue.4 , pp. 808-816
    • Wang, X.1    Sanyal, A.2    Cawthon, P.M.3    Palermo, L.4    Jekir, M.5    Christensen, J.6    Ensrud, K.E.7    Cummings, S.R.8    Orwoll, E.9    Black, D.M.10
  • 27
    • 84891491111 scopus 로고    scopus 로고
    • Early changes in bone turnover markers (BTMs) predict vertebral strength changes in teriparatide- or alendronate-treated postmenopausal women with osteoporosis [abstract]
    • Chen P, Glass EV, Krege JH., Early changes in bone turnover markers (BTMs) predict vertebral strength changes in teriparatide- or alendronate-treated postmenopausal women with osteoporosis [abstract]. In: ENDO 2007 Program & Abstracts. Toronto: Endocrine Society; June 2007.
    • (2007) ENDO 2007 Program & Abstracts. Toronto: Endocrine Society; June
    • Chen, P.1    Glass, E.V.2    Krege, J.H.3
  • 28
    • 77953388933 scopus 로고    scopus 로고
    • Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS Study
    • Mar;.
    • Borggrefe J, Graeff C, Nickelsen TN, Marin F, Gluer CC., Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS Study. J Bone Miner Res. 2010 Mar; 25 (3): 472-81.
    • (2010) J Bone Miner Res. , vol.25 , Issue.3 , pp. 472-481
    • Borggrefe, J.1    Graeff, C.2    Nickelsen, T.N.3    Marin, F.4    Gluer, C.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.